Search Results

Lone Star Bio

StemBioSys Announces Launch of CELLvo™ Atrial Cardiomyocyte, a Technological Leap Forward in Cardiotoxicity Screening

StemBioSys, Inc. announced the launch of CELLvo™ Atrial Cardiomyocyte, a “chamber specific” human induced pluripotent stem cell derived cardiomyocyte designed to function identically to human atrial cardiomyocytes.

June 13, 2023

·

4 min read

Lone Star Bio

StemBioSys Announces Launch of NeuroMatrix™, a Technological Leap Forward in Laboratory Production of Functionally Mature Human Neural Cell Types

StemBioSys, Inc. (StemBioSys) announced today the launch of NeuroMatrix™, an astrocyte-derived extracellular matrix that enables the culture of human induced pluripotent stem cell (hiPSC) derived and primary neural cell types.

February 13, 2023

·

3 min read

Deals

Curi Bio Acquires CarTox™ Technology from StemBioSys, Announces Launch of Nautilus™ Optical Mapping System

Curi Bio, a leading developer of human stem cell-based platforms and technologies for drug discovery, today announced the exclusive commercial acquisition from StemBioSys of the CarTox™ technology platform for calcium and voltage optical mapping.

March 29, 2022

·

6 min read

BioMidwest

StemBioSys and Cartox Announce Publication of Research Demonstrating CELLvo™ Matrix Plus Significantly Enhances the Functionality of hiPSC Cardiomyocytes

StemBioSys, Inc. (StemBioSys) and CarTox, Inc. (Cartox) announced today the publication of research in Nature Scientific Reports demonstrating that CELLvo™ Matrix Plus, an extracellular matrix (ECM) technology derived from human perinatal stem cells,

November 9, 2020

·

5 min read

Lone Star Bio

StemBioSys, Inc. to Participate in Biotech Showcase Digital During “J.P. Morgan Week 2021"

StemBioSys, Inc., a privately held biomedical company that manufactures and develops innovative, advanced human stem cell technologies to improve the predictive power of pre-clinical drug safety screening, today announced its President and Chief Executive Officer Bob Hutchens will participate in Biotech Showcase Digital bei

December 16, 2020

·

2 min read

Business

Gemini Bio-Products and StemBioSys Announce Strategic Partnership

Gemini Bio-Products (“Gemini”) and StemBioSys are pleased to announce a strategic partnership that will bring StemBioSys’ entire selection of matrices and cells into the Gemini portfolio

February 13, 2019

·

2 min read

Biotech Beach

How This Senior Scientist Got A Job At StemBioSys

March 27, 2017

·

1 min read

Business

StemBioSys Release: Company Announces U.S. And Canadian Distribution Agreement With VWR International, Inc.

January 18, 2017

·